Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mapracorat for ocular inflammation and pain following cataract surgery
NCT01591655Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jul 2012
- Primary completion
- Sep 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mapracorat in ocular inflammation, sponsored by Bausch + Lomb. Started Jul 2012; status: completed.
02
Drugs
mapracorat
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT01591655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01591655.